C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for allograft loss.
Transplant Therapeutics Consortium’s iBox Scoring System becomes first EMA-qualified endpoint for transplant
